First FDA-approved treatment in HER2-positive metastatic colorectal cancer –
– Combination regimen is approved for use in the second-line treatment setting and beyond –
https://finance.yahoo.com/news/seagen-announces-fda-accelerated-approval-192100432.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.